Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BEKE-W
02423
5
BIDU-SW
09888
No Data
BioVie Q1 EPS $(0.98) Misses $(0.79) Estimate
BioVie | 10-Q: Quarterly report
BioVie Inc.'s NE3107 Study: A New Hope for Early Parkinson's Treatment
BioVie | 10-K: FY2025 Annual Report
BioVie To Present Poster Highlighting Design And Enrichment Strategy Of Its Ongoing Phase 2 ADDRESS-LC Trial At Keystone Symposia
Express News | BioVie Highlighted Address-Lc Phase 2 Trial Design Exploring Bezisterim for the Treatment of Neurological Symptoms of Long Covid at Keystone Symposia on Long Covid and Other Post-Acute Infection Syndromes